2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide

C138H147N41O24S2 — CID 160987407

IUPAC2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide
SMILESCOCCOc1ccc2c(c1)C(=O)N(c1ncc(C(=O)Nc3cnccc3N3CCNCC3)o1)C2.COc1cccc(N2CCN(c3ncc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(-n2c(=O)n(CCN3CCOCC3)c3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(-n2cnc3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(N2Cc3ccc(S(=O)(=O)N4CCCC4)cc3C2=O)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(N2Cc3ccccc3S2(=O)=O)o1
InChIInChI=1S/C26H30N8O4.C25H27N7O5S.C24H26N6O5.C23H25N7O4.C20H19N7O2.C20H20N6O4S/c35-24(30-19-17-28-6-5-20(19)32-9-7-27-8-10-32)23-18-29-25(38-23)34-22-4-2-1-3-21(22)33(26(34)36)12-11-31-13-15-37-16-14-31;33-23(29-20-14-27-6-5-21(20)30-11-7-26-8-12-30)22-15-28-25(37-22)32-16-17-3-4-18(13-19(17)24(32)34)38(35,36)31-9-1-2-10-31;1-33-10-11-34-17-3-2-16-15-30(23(32)18(16)12-17)24-27-14-21(35-24)22(31)28-19-13-26-5-4-20(19)29-8-6-25-7-9-29;1-33-17-4-2-3-16(13-17)29-11-12-30(23(29)32)22-26-15-20(34-22)21(31)27-18-14-25-6-5-19(18)28-9-7-24-8-10-28;28-19(25-15-11-22-6-5-16(15)26-9-7-21-8-10-26)18-12-23-20(29-18)27-13-24-14-3-1-2-4-17(14)27;27-19(24-15-11-22-6-5-16(15)25-9-7-21-8-10-25)17-12-23-20(30-17)26-13-14-3-1-2-4-18(14)31(26,28)29/h1-6,17-18,27H,7-16H2,(H,30,35);3-6,13-15,26H,1-2,7-12,16H2,(H,29,33);2-5,12-14,25H,6-11,15H2,1H3,(H,28,31);2-6,13-15,24H,7-12H2,1H3,(H,27,31);1-6,11-13,21H,7-10H2,(H,25,28);1-6,11-12,21H,7-10,13H2,(H,24,27)
InChIKeyTUDULEULTNXASV-UHFFFAOYSA-N
MW2828.09 g/mol
LogP10.46
Rot. Bonds35

About 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide

2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide (PubChem CID 160987407) has the molecular formula C138H147N41O24S2 and a molecular weight of 2828.09 g/mol. Its IUPAC name is 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide.

Molecular Properties

Compound Name2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide
PubChem CID160987407
Molecular FormulaC138H147N41O24S2
Molecular Weight2828.09 g/mol
Exact Mass2826.10
IUPAC Name2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide
SMILESCOCCOc1ccc2c(c1)C(=O)N(c1ncc(C(=O)Nc3cnccc3N3CCNCC3)o1)C2.COc1cccc(N2CCN(c3ncc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(-n2c(=O)n(CCN3CCOCC3)c3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(-n2cnc3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(N2Cc3ccc(S(=O)(=O)N4CCCC4)cc3C2=O)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(N2Cc3ccccc3S2(=O)=O)o1
InChIInChI=1S/C26H30N8O4.C25H27N7O5S.C24H26N6O5.C23H25N7O4.C20H19N7O2.C20H20N6O4S/c35-24(30-19-17-28-6-5-20(19)32-9-7-27-8-10-32)23-18-29-25(38-23)34-22-4-2-1-3-21(22)33(26(34)36)12-11-31-13-15-37-16-14-31;33-23(29-20-14-27-6-5-21(20)30-11-7-26-8-12-30)22-15-28-25(37-22)32-16-17-3-4-18(13-19(17)24(32)34)38(35,36)31-9-1-2-10-31;1-33-10-11-34-17-3-2-16-15-30(23(32)18(16)12-17)24-27-14-21(35-24)22(31)28-19-13-26-5-4-20(19)29-8-6-25-7-9-29;1-33-17-4-2-3-16(13-17)29-11-12-30(23(29)32)22-26-15-20(34-22)21(31)27-18-14-25-6-5-19(18)28-9-7-24-8-10-28;28-19(25-15-11-22-6-5-16(15)26-9-7-21-8-10-26)18-12-23-20(29-18)27-13-24-14-3-1-2-4-17(14)27;27-19(24-15-11-22-6-5-16(15)25-9-7-21-8-10-25)17-12-23-20(30-17)26-13-14-3-1-2-4-18(14)31(26,28)29/h1-6,17-18,27H,7-16H2,(H,30,35);3-6,13-15,26H,1-2,7-12,16H2,(H,29,33);2-5,12-14,25H,6-11,15H2,1H3,(H,28,31);2-6,13-15,24H,7-12H2,1H3,(H,27,31);1-6,11-13,21H,7-10H2,(H,25,28);1-6,11-12,21H,7-10,13H2,(H,24,27)
InChIKeyTUDULEULTNXASV-UHFFFAOYSA-N
XLogP10.46
TPSA723.58 Ų
H-Bond Donors12
H-Bond Acceptors53
Rotatable Bonds35
Heavy Atoms205
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002828.09
LogP ≤ 510.46
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1053

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide?
The IUPAC name of 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide (CID 160987407) is 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide.
What is the SMILES notation for 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide?
The canonical SMILES for 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide is COCCOc1ccc2c(c1)C(=O)N(c1ncc(C(=O)Nc3cnccc3N3CCNCC3)o1)C2.COc1cccc(N2CCN(c3ncc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(-n2c(=O)n(CCN3CCOCC3)c3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(-n2cnc3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(N2Cc3ccc(S(=O)(=O)N4CCCC4)cc3C2=O)o1.O=C(Nc1cnccc1N1CCNCC1)c1cnc(N2Cc3ccccc3S2(=O)=O)o1.
What is the InChIKey of 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide?
The InChIKey is TUDULEULTNXASV-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30N8O4.C25H27N7O5S.C24H26N6O5.C23H25N7O4.C20H19N7O2.C20H20N6O4S/c35-24(30-19-17-28-6-5-20(19)32-9-7-27-8-10-32)23-18-29-25(38-23)34-22-4-2-1-3-21(22)33(26(34)36)12-11-31-13-15-37-16-14-31;33-23(29-20-14-27-6-5-21(20)30-11-7-26-8-12-30)22-15-28-25(37-22)32-16-17-3-4-18(13-19(17)24(32)34)38(35,36)31-9-1-2-10-31;1-33-10-11-34-17-3-2-16-15-30(23(32)18(16)12-17)24-27-14-21(35-24)22(31)28-19-13-26-5-4-20(19)29-8-6-25-7-9-29;1-33-17-4-2-3-16(13-17)29-11-12-30(23(29)32)22-26-15-20(34-22)21(31)27-18-14-25-6-5-19(18)28-9-7-24-8-10-28;28-19(25-15-11-22-6-5-16(15)26-9-7-21-8-10-26)18-12-23-20(29-18)27-13-24-14-3-1-2-4-17(14)27;27-19(24-15-11-22-6-5-16(15)25-9-7-21-8-10-25)17-12-23-20(30-17)26-13-14-3-1-2-4-18(14)31(26,28)29/h1-6,17-18,27H,7-16H2,(H,30,35);3-6,13-15,26H,1-2,7-12,16H2,(H,29,33);2-5,12-14,25H,6-11,15H2,1H3,(H,28,31);2-6,13-15,24H,7-12H2,1H3,(H,27,31);1-6,11-13,21H,7-10H2,(H,25,28);1-6,11-12,21H,7-10,13H2,(H,24,27).
What are the key properties of 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide?
2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide has a molecular weight of 2828.09 g/mol, XLogP of 10.46, 35 rotatable bonds, 12 hydrogen bond donors, and 53 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(1,1-dioxo-3H-1,2-benzothiazol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[5-(2-methoxyethoxy)-3-oxo-1H-isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide;2-(3-oxo-5-pyrrolidin-1-ylsulfonyl-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-5-carboxamide is sourced from PubChem (CID 160987407), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).